当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Lexi Augustine
In-depth study is being done on the secretome formed from dental pulp a stem (DSC) cell, which is made up of a variety of biomolecules, and its therapeutic potential. Because the paracrine effect of the bioactive factors secreted by human dental pulp stem cells (hDPSCs) and human exfoliated deciduous teeth (SHEDs) is not fully understood, the majority of DSC secretome-based therapies have not been applied in human medicine, despite promising in vitro and in vivo studies. We summarise the available research on the secretome produced from hDPSC and SHED as a possible participant in the regeneration of bone, cartilage, and nerve tissue in this review. According to published studies, dental MSC-derived secretome/conditional medium can regulate neuroprotective, anti-inflammatory, anti-apoptotic, and angiogenic processes through secretome paracrine mechanisms, which may be useful in treating neurodegenerative diseases, neural injuries, cartilage defects, and bone repair. Similar to bone marrow MSC-secretomes, dental MSCsecretomes engage cellular and molecular pathways that affect how well cell-free therapy works. The multidirectional paracrine effect that dental MSC-derived secretomes have been shown to have in the treatment of numerous different wounded tissues is emphasised in many papers as having potential applications in tissue-regenerating therapy [1].